[Asia Economy Reporter Jang Hyowon] Intromedic, a company specializing in capsule endoscopy, is showing strong performance as it is known to be a key investor in the revival of Cyworld.
As of 9:51 AM on the 18th, Intromedic's stock price is trading at 2,430 KRW, up 6.81% compared to the previous trading day.
The news that Cyworld plans to list and use cryptocurrency instead of 'Dotori' appears to be influencing the stock price as well.
Cyworld is expected to transform by leveraging the Metaverse and cryptocurrency, and Intromedic is a major investor in Cyworld Z, a newly established corporation that acquired the service operation rights of Cyworld. Intromedic is expected to provide various development and operational funding following the service resumption.
Meanwhile, the U.S. online gaming company 'Roblox' saw its stock price rise more than 54% above the reference price on its direct listing debut on the New York Stock Exchange, becoming a company valued at $45.2 billion (approximately 51.32 trillion KRW).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
